Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmaPrint

This article was originally published in The Tan Sheet

Executive Summary

Ken Gorelick, MD, on board as senior VP-R&D and chief medical officer at the Irvine Calif.-based developer of dietary supplements derived from natural plant extracts. Gorelick most recently was with DuPont Merck as VP, product planning & acquisition and VP, clinical R&D. He also is affiliated with Stanford University Medical School. PharmaPrint developed the line of supplements soon to be introduced by American Home Products under the Centrum banner...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel